Andreas Bergthaler

Andreas Bergthaler

Auto-generated profile, based on publicly available information

Andreas Bergthaler

Institute for Hygiene and Applied Immunology, Medical University of Vienna, Vienna, Austria

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Nature
Verified
Journal Article
Closed access
PDF file
TKThomas Krausgruber
Thomas Krausgruber
NFNikolaus Fortelny
Nikolaus Fortelny
VFVictoria Fife-Gernedl
Victoria Fife-Gernedl
MSMartin Senekowitsch
Martin Senekowitsch
LSLinda C. Schuster
Linda C. Schuster
CBChristoph Bock
Christoph Bock

1 November 2017 in Gastroenterology
Verified
Journal Article
Open access
PDF file
AHAhmed N. Hegazy
Ahmed N. Hegazy
NWNathaniel R. West
Nathaniel R. West
MSMichael J.T. Stubbington
Michael J.T. Stubbington
EWEmily Wendt
Emily Wendt
KSKim I.M. Suijker
Kim I.M. Suijker
FPFiona Powrie
Fiona Powrie
Background & Aims Interactions between commensal microbes and the immune system are tightly regulated and maintain intestinal homeostasis, but little is known about these interactions in humans. We investigated responses of human CD4+ T cells to the intestinal microbiota. We measured the abundance of T cells in circulation and intestinal tissues that respond to intestinal microbes and determined their clonal diversity. We also assessed their functional phenotypes and effects on intestinal resident cell populations, and studied alterations in microbe-reactive T cells in patients with chronic intestinal inflammation. Methods We collected samples of peripheral blood mononuclear cells and intestinal tissues from healthy individuals (controls, n = 13−30) and patients with inflammatory bowel diseases (n = 119; 59 with ulcerative colitis and 60 with Crohn’s disease). We used 2 independent assays (CD154 detection and carboxy-fluorescein succinimidyl ester dilution assays) and 9 intestinal bacterial species (Escherichia coli, Lactobacillus acidophilus, Bifidobacterium animalis subsp lactis, Faecalibacterium prausnitzii, Bacteroides vulgatus, Roseburia intestinalis, Ruminococcus obeum, Salmonella typhimurium, and Clostridium difficile) to quantify, expand, and characterize microbe-reactive CD4+ T cells. We sequenced T-cell receptor Vβ genes in expanded microbe-reactive T-cell lines to determine their clonal diversity. We examined the effects of microbe-reactive CD4+ T cells on intestinal stromal and epithelial cell lines. Cytokines, chemokines, and gene expression patterns were measured by flow cytometry and quantitative polymerase chain reaction. Results Circulating and gut-resident CD4+ T cells from controls responded to bacteria at frequencies of 40−4000 per million for each bacterial species tested. Microbiota-reactive CD4+ T cells were mainly of a memory phenotype, present in peripheral blood mononuclear cells and intestinal tissue, and had a diverse T-cell receptor Vβ repertoire. These cells were functionally heterogeneous, produced barrier-protective cytokines, and stimulated intestinal stromal and epithelial cells via interleukin 17A, interferon gamma, and tumor necrosis factor. In patients with inflammatory bowel diseases, microbiota-reactive CD4+ T cells were reduced in the blood compared with intestine; T-cell responses that we detected had an increased frequency of interleukin 17A production compared with responses of T cells from blood or intestinal tissues of controls. Conclusions In an analysis of peripheral blood mononuclear cells and intestinal tissues from patients with inflammatory bowel diseases vs controls, we found that reactivity to intestinal bacteria is a normal property of the human CD4+ T-cell repertoire, and does not necessarily indicate disrupted interactions between immune cells and the commensal microbiota. T-cell responses to commensals might support intestinal homeostasis, by producing barrier-protective cytokines and providing a large pool of T cells that react to pathogens.

1 January 2010 in Immunity
Verified
Journal Article
Closed access
AHAhmed N. Hegazy
Ahmed N. Hegazy
MPMichael Peine
Michael Peine
CHCaroline Helmstetter
Caroline Helmstetter
IPIsabel Panse
Isabel Panse
AFAnja Fröhlich
Anja Fröhlich
MLMax Löhning
Max Löhning

9 December 2020 in Science Translational Medicine
Verified
Journal Article
Open access
PDF file
APAlexandra Popa
Alexandra Popa
JGJakob-Wendelin Genger
Jakob-Wendelin Genger
MNMichael D. Nicholson
Michael D. Nicholson
TPThomas Penz
Thomas Penz
DSDaniela Schmid
Daniela Schmid
ABAndreas Bergthaler
Andreas Bergthaler
Superspreading events shaped the Coronavirus Disease 2019 (COVID-19) pandemic, and their rapid identification and containment are essential for disease control. Here we provide a national-scale analysis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) superspreading during the first wave of infections in Austria, a country that played a major role in initial virus transmissions in Europe. Capitalizing on Austria’s well-developed epidemiological surveillance system, we identified major SARS-CoV-2 clusters during the first wave of infections and performed deep whole-genome sequencing of more than 500 virus samples. Phylogenetic-epidemiological analysis enabled the reconstruction of superspreading events and charts a map of tourism-related viral spread originating from Austria in spring 2020. Moreover, we exploited epidemiologically well-defined clusters to quantify SARS-CoV-2 mutational dynamics, including the observation of a low-frequency mutation that progressed to fixation within the infection chain. Time-resolved virus sequencing unveiled viral mutation dynamics within individuals with COVID-19, and epidemiologically validated infector-infectee pairs enabled us to determine an average transmission bottleneck size of 103 SARS-CoV-2 particles. In conclusion, this study illustrates the power of combining epidemiological analysis with deep viral genome sequencing to unravel the spread of SARS-CoV-2, and to gain fundamental insights into mutational dynamics and transmission properties.

18 July 2022 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
FAFabian Amman
Fabian Amman
RMRudolf Markt
Rudolf Markt
LELukas Endler
Lukas Endler
SHSebastian Hupfauf
Sebastian Hupfauf
BABenedikt Agerer
Benedikt Agerer
ABAndreas Bergthaler
Andreas Bergthaler

4 October 2021 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
HBHatoon Baazim
Hatoon Baazim
LALaura Antonio-Herrera
Laura Antonio-Herrera
ABAndreas Bergthaler
Andreas Bergthaler